# Lavender Anxiety Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/lavender-anxiety-meta-analysis-evidence-review
Category: evidence-review
Summary: Lavender Anxiety Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systemat
Last reviewed: 2026-06-28
Reviewed by: Migaku Evidence Review
# Lavender Anxiety Meta-analysis: What the Evidence Says

## Quick Answer

Lavender Anxiety Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of aromatherapy on objective physiological outcomes in adult ICU patients: a systematic review | systematic review | 1 | 2026-06-03 | 10.3389/fmed.2026.1807990 |
| Aromatherapy for Labour Pain Management: Umbrella Review | narrative review | 3 | 2026-02-25 | 10.3390/healthcare14050573 |

## What The Sources Report

- Despite its widespread use, the scientific evidence supporting aromatherapy's efficacy remains limited by methodological shortcomings, most notably, a reliance on subjective outcome measures such as patient satisfaction, psychometric scales, and self-reported assessments. [Moyano Pedro Almeida (2026); evidence level 1]
- Systematic reviews and methodological critiques published in recent years explicitly recommend the adoption of standardized physiological parameters (e.g., heart rate, blood pressure, respiratory rate) and biochemical markers (e.g., cortisol, inflammatory cytokines) as primary endpoints (,,). [Moyano Pedro Almeida (2026); evidence level 1]
- Despite its widespread use, its role within evidence-based practice remains controversial, as scientific studies provide heterogeneous and sometimes contradictory results. [Breuninger Nicole (2026); evidence level 3]
- Despite anecdotal and clinical support, the evidence for aromatherapy in labour remains fragmented. [Breuninger Nicole (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For lavender anxiety meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Moyano Pedro Almeida (2026). Effects of aromatherapy on objective physiological outcomes in adult ICU patients: a systematic review. DOI: 10.3389/fmed.2026.1807990. PMCID: PMC13272137. PMID: 42318382. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13272137/
- Breuninger Nicole (2026). Aromatherapy for Labour Pain Management: Umbrella Review. DOI: 10.3390/healthcare14050573. PMCID: PMC12984763. PMID: 41827525. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12984763/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.